These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 22941172

  • 1. The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.
    Yang PW, Hsieh CY, Kuo FT, Huang PM, Hsu HH, Kuo SW, Chen JS, Lee JM.
    Ann Surg Oncol; 2013 Feb; 20(2):562-71. PubMed ID: 22941172
    [Abstract] [Full Text] [Related]

  • 2. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
    Rafiq R, Bhat GA, Lone MM, Masood A, Dar NA.
    Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM, Li Y, Wang N, Zhang XJ, Dong XJ, Guo W.
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China.
    Guo W, Zhou RM, Wan LL, Wang N, Li Y, Zhang XJ, Dong XJ.
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):263-70. PubMed ID: 17653764
    [Abstract] [Full Text] [Related]

  • 5. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS.
    Cancer; 2012 Feb 01; 118(3):689-97. PubMed ID: 21751198
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.
    Umar M, Upadhyay R, Prakash G, Kumar S, Ghoshal UC, Mittal B.
    Mol Carcinog; 2013 Nov 01; 52 Suppl 1():E10-8. PubMed ID: 22692992
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
    Lee JM, Yang SY, Yang PW, Shun CT, Wu MT, Hsu CH, Lin CC, Cheng JC, Wang YH, Chuang TH, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC.
    Ann Surg Oncol; 2011 Jul 01; 18(7):2066-73. PubMed ID: 21298351
    [Abstract] [Full Text] [Related]

  • 8. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
    Yang PW, Huang YC, Hsieh CY, Hua KT, Huang YT, Chiang TH, Chen JS, Huang PM, Hsu HH, Kuo SW, Kuo ML, Lee JM.
    Ann Surg Oncol; 2014 Dec 01; 21 Suppl 4():S601-9. PubMed ID: 24770678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M, Moreno I, Navarro A, Ibeas R, Artells R, Gel B, Martinez F, Moreno J, Hernandez R, Navarro-Vigo M.
    Oncology; 2007 Dec 01; 72(5-6):364-70. PubMed ID: 18204222
    [Abstract] [Full Text] [Related]

  • 11. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.
    J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002
    [Abstract] [Full Text] [Related]

  • 12. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP, Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, Moon H, Friedberg E, van der Horst GT, Hoeijmakers JH, Vijg J, van Steeg H.
    Cancer Res; 2008 Mar 01; 68(5):1347-53. PubMed ID: 18316597
    [Abstract] [Full Text] [Related]

  • 13. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X.
    Clin Cancer Res; 2005 Feb 15; 11(4):1408-15. PubMed ID: 15746040
    [Abstract] [Full Text] [Related]

  • 14. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K.
    Lung Cancer; 2011 Aug 15; 73(2):138-46. PubMed ID: 21195504
    [Abstract] [Full Text] [Related]

  • 15. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Guo W, Cui YJ, Fang SM, Li Y, Wang N, Zhang JH.
    Ai Zheng; 2006 Feb 15; 25(2):194-9. PubMed ID: 16480585
    [Abstract] [Full Text] [Related]

  • 16. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P.
    Carcinogenesis; 2004 Dec 15; 25(12):2433-41. PubMed ID: 15333465
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
    Azad AK, Bairati I, Samson E, Cheng D, Mirshams M, Qiu X, Savas S, Waldron J, Wang C, Goldstein D, Xu W, Meyer F, Liu G.
    Clin Cancer Res; 2012 Jan 01; 18(1):196-206. PubMed ID: 22076708
    [Abstract] [Full Text] [Related]

  • 19. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL, Hu Y.
    Ann Thorac Surg; 2012 May 01; 93(5):1682-8. PubMed ID: 22480390
    [Abstract] [Full Text] [Related]

  • 20. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y.
    Ann Surg Oncol; 2010 Mar 01; 17(3):804-11. PubMed ID: 19885698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.